Home>Topics>Finance>Ceos>Fred Hassan

Fred Hassan

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
  1. New Morningstar Analyst Report for Avon Products Inc

    Stock Reports

    Wed, 18 Jun 2014

    Jung (who held the top spot for about 12 years and stepped down as chairman at the end of 2012) and former chairman Fred Hassan (who announced he would be leaving his post in light of "other professional commitments," which we now know stem

  2. UPDATE 1-Avon says Fred Hassan resigns from board

    Headlines

    Fri, 26 Apr 2013

    April 26 (Reuters) - Avon Products Inc said on Friday that longtime board member Fred Hassan resigned from its board to focus on his other professional commitments and that Doug Conant was taking...

  3. Avon says Fred Hassan resigns from board due to other commitments

    Headlines

    Fri, 26 Apr 2013

    April 26 (Reuters) - Avon Products Inc said on Friday that Fred Hassan has resigned from its board and that the chief financial officer will temporarily fill a spot.

  4. Avon Takes Steps to Enhance its Corporate Governance; Shares Far From a Beauty

    Commentary

    Fri, 26 Apr 2013

    Avon Products AVP announced on Friday that independent chairman Fred Hassan would be stepping down immediately in light of " his other professional commitments" (which presently include working as a managing

  5. Jung to Step Down as Chairman as Avon Attempts to Close Book on Troubled Chapter

    Commentary

    Fri, 5 Oct 2012

    Andrea Jung (who held the top spot for 12 years) will step down as chairman at the end of the year as a positive one. Fred Hassan will succeed Jung, who will continue to serve as a senior advisor, as nonexecutive chairman; we applaud the separation

  6. Schering Adapts to Challenges

    Commentary

    Thu, 3 Apr 2008

    offset the weakness in its cholesterol franchise and maximize the profit potential from the Organon acquisition. CEO Fred Hassan and his management team successfully restructured the company when faced with the loss of allergy drug Claritin several

  7. Stock Analyst Note - Schering-Plough

    Commentary

    Mon, 1 Dec 2003

    for a 30% discount before considering them. The company's near-term restructuring plans held few surprises. CEO Fred Hassan has recruited numerous senior managers from outside the company (mostly from Hassan's legacy, Pharmacia) and initiated

  8. Stock Analyst Note - Schering-Plough

    Commentary

    Thu, 24 Jul 2003

    combination of products and financial wherewithal to rebuild, in our opinion. New leadership is also key, and new CEO Fred Hassan understands this. He's set in motion the necessary changes for a turnaround. He replaced senior management with

  9. Schering-Plough Cuts Estimates

    Commentary

    Mon, 7 Jul 2003

    erosion will be clearer after second-quarter earnings are released July 23. Despite the company's troubles, we think Fred Hassan 's management changes combined with strong Zetia sales could be enough to rescue Schering-Plough from the smoldering

  10. Indictment Likely for Schering

    Commentary

    Mon, 2 Jun 2003

    came from, so financially, it can take the blow. Even so, we think Schering-Plough is a toxic stock until new CEO Fred Hassan has exorcised the company's demons. We'd look elsewhere.

« Prev12Next »
Content Partners